Juvenescence launches Souvien Therapeutics to address neurodegenerative diseases

Juvenescence launches Souvien Therapeutics to address neurodegenerative diseases

Source: 
Pharmaceutical Business Review
snippet: 

Juvenescence, a life sciences company developing therapeutics and technologies to treat diseases of aging and increase human longevity, is pleased to announce its latest biotech company Souvien Therapeutics (“Souvien”), creating innovative medicines to address neurodegenerative diseases by targeting the epigenetic underpinnings of neurodegeneration.